These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 32511516)

  • 1. Robust ACE2 protein expression localizes to the motile cilia of the respiratory tract epithelia and is not increased by ACE inhibitors or angiotensin receptor blockers.
    Lee IT; Nakayama T; Wu CT; Goltsev Y; Jiang S; Gall PA; Liao CK; Shih LC; Schürch CM; McIlwain DR; Chu P; Borchard NA; Zarabanda D; Dholakia SS; Yang A; Kim D; Kanie T; Lin CD; Tsai MH; Phillips KM; Kim R; Overdevest JB; Tyler MA; Yan CH; Lin CF; Lin YT; Bau DT; Tsay GJ; Patel ZM; Tsou YA; Tai CJ; Yeh TH; Hwang PH; Nolan GP; Nayak JV; Jackson PK
    medRxiv; 2020 May; ():. PubMed ID: 32511516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs.
    Lee IT; Nakayama T; Wu CT; Goltsev Y; Jiang S; Gall PA; Liao CK; Shih LC; Schürch CM; McIlwain DR; Chu P; Borchard NA; Zarabanda D; Dholakia SS; Yang A; Kim D; Chen H; Kanie T; Lin CD; Tsai MH; Phillips KM; Kim R; Overdevest JB; Tyler MA; Yan CH; Lin CF; Lin YT; Bau DT; Tsay GJ; Patel ZM; Tsou YA; Tzankov A; Matter MS; Tai CJ; Yeh TH; Hwang PH; Nolan GP; Nayak JV; Jackson PK
    Nat Commun; 2020 Oct; 11(1):5453. PubMed ID: 33116139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [ACE-inhibitors, angiotensin receptor blockers and severe acute respiratory syndrome caused by coronavirus].
    Verdecchia P; Reboldi G; Cavallini C; Mazzotta G; Angeli F
    G Ital Cardiol (Rome); 2020 May; 21(5):321-327. PubMed ID: 32310915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells.
    Okoloko O; Vanderwall ER; Rich LM; White MP; Reeves SR; Harrington WE; Barrow KA; Debley JS
    Front Pharmacol; 2021; 12():765951. PubMed ID: 34867390
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of ACE inhibitors and angiotensin type II blockers with ACE2 overexpression in COVID-19 comorbidities: A pathway-based analytical study.
    Parit R; Jayavel S
    Eur J Pharmacol; 2021 Apr; 896():173899. PubMed ID: 33508281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review.
    Aleksova A; Gagno G; Sinagra G; Beltrami AP; Janjusevic M; Ippolito G; Zumla A; Fluca AL; Ferro F
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the SARS-CoV-2 receptorACE2 in human heart is associated with uncontrolled diabetes, obesity, and activation of the renin angiotensin system.
    Herman-Edelstein M; Guetta T; Barnea A; Waldman M; Ben-Dor N; Barac YD; Kornowski R; Arad M; Hochhauser E; Aravot D
    Cardiovasc Diabetol; 2021 Apr; 20(1):90. PubMed ID: 33906662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker treatment and haemodynamic factors are associated with increased cardiac mRNA expression of angiotensin-converting enzyme 2 in patients with cardiovascular disease.
    Lebek S; Tafelmeier M; Messmann R; Provaznik Z; Schmid C; Maier LS; Birner C; Arzt M; Wagner S
    Eur J Heart Fail; 2020 Dec; 22(12):2248-2257. PubMed ID: 33017071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.
    Danser AHJ; Epstein M; Batlle D
    Hypertension; 2020 Jun; 75(6):1382-1385. PubMed ID: 32208987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-angiotensin system blockade on angiotensin-converting enzyme 2 and TMPRSS2 in human type II pneumocytes.
    Silva MG; Falcoff NL; Corradi GR; Alfie J; Seguel RF; Tabaj GC; Iglesias LI; Nuñez M; Guman GR; Gironacci MM
    Life Sci; 2022 Mar; 293():120324. PubMed ID: 35032553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy.
    Chung MK; Karnik S; Saef J; Bergmann C; Barnard J; Lederman MM; Tilton J; Cheng F; Harding CV; Young JB; Mehta N; Cameron SJ; McCrae KR; Schmaier AH; Smith JD; Kalra A; Gebreselassie SK; Thomas G; Hawkins ES; Svensson LG
    EBioMedicine; 2020 Aug; 58():102907. PubMed ID: 32771682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-Expression and Localization of Angiotensin-Converting Enzyme-2 (ACE2) and the Transmembrane Serine Protease 2 (TMPRSS2) in Paranasal Ciliated Epithelium of Patients with Chronic Rhinosinusitis.
    Kawasumi T; Takeno S; Ishino T; Ueda T; Hamamoto T; Takemoto K; Horibe Y; Takashi O
    Am J Rhinol Allergy; 2022 May; 36(3):313-322. PubMed ID: 34989246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers During the COVID-19 Pandemic: A Modeling Analysis.
    Sadria M; Layton AT
    PLoS Comput Biol; 2020 Oct; 16(10):e1008235. PubMed ID: 33031368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension: A Single-Center Retrospective Study.
    Yang G; Tan Z; Zhou L; Yang M; Peng L; Liu J; Cai J; Yang R; Han J; Huang Y; He S
    Hypertension; 2020 Jul; 76(1):51-58. PubMed ID: 32348166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies.
    Kriszta G; Kriszta Z; Váncsa S; Hegyi PJ; Frim L; Erőss B; Hegyi P; Pethő G; Pintér E
    Front Pharmacol; 2021; 12():619524. PubMed ID: 33762942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia.
    Jia HP; Look DC; Shi L; Hickey M; Pewe L; Netland J; Farzan M; Wohlford-Lenane C; Perlman S; McCray PB
    J Virol; 2005 Dec; 79(23):14614-21. PubMed ID: 16282461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme 2 and kidney diseases in the era of coronavirus disease 2019.
    Suh SH; Ma SK; Kim SW; Bae EH
    Korean J Intern Med; 2021 Mar; 36(2):247-262. PubMed ID: 33617712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of renin-angiotensin-aldosterone system inhibitors on plasma levels of angiotensin-converting enzyme 2.
    Zimmermann T; Walter JE; Lopez-Ayala P; Strebel I; Amrein M; Koechlin M; Honegger U; Mueller C;
    ESC Heart Fail; 2021 Apr; 8(2):1717-1721. PubMed ID: 34596976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.
    Shukla AK; Banerjee M
    High Blood Press Cardiovasc Prev; 2021 Mar; 28(2):129-139. PubMed ID: 33635533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin-angiotensin-aldosterone system and COVID-19 infection.
    Alexandre J; Cracowski JL; Richard V; Bouhanick B;
    Ann Endocrinol (Paris); 2020 Jun; 81(2-3):63-67. PubMed ID: 32370986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.